- Display 15 Products per page
Remote Patient Monitoring and Telehealth Markets, 12th Edition
Published: April 29, 2021 | Price: $4,000.00 – $8,000.00
The global patient monitoring and telehealth market has continued its expansion in both the institutional and home segments of the health market with the United States and many European countries at the forefront of implementation. Market numbers discussed in this report are focused on the global patient monitoring and telehealth market with special market coverage of the specific regions and countries, including: North America (the United States, Canada, Mexico) Europe (the United Kingdom, Germany, France, Italy) Middle East (Iran, Iraq)...
Clinical Laboratory Services Market, 6th Edition
Published: June 8, 2021 | Price: $4,000.00 – $8,000.00
Clinical Laboratory Services Market, 6th Edition, new from Kalorama Information, provides an overview of the clinical laboratory industry and the trends driving growth. Included in the report are statistics influencing the industry, incidence of diseases in the U.S. and worldwide demographics, life expectancy, and company strategies. Information is presented as a global focused market report, with key regions discussed including: North America (United States, Canada) Europe, Middle East, and Africa - EMEA (Germany, France, Italy, Spain, United Kingdom, Switzerland) Asia...
United States Market for In Vitro Diagnostic (IVD) Tests
Published: June 7, 2021 | Price: $4,000.00 – $8,000.00
The U.S. market dominates the IVD industry AND remains the core geographical IVD market in the world. Yet this major multi-billion-dollar IVD market is in a state of flux, trying to manage a myriad of issues, all of which collide with a huge system that costs more than any other in the world. COVID-19 had a profound effect on the IVD diagnostic industry – some segments exploded and others languished. At this point in time, it is hard to predict...
The Market for In Vitro Diagnostic Tests in Latin America
Published: June 29, 2021 | Price: $4,000.00 – $8,000.00
Latin America (LATAM) is a key target for IVD manufacturers exploring expansion opportunities. This report, The Market for In Vitro Diagnostic Tests in Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela and other nations), focuses on the market for reagents and instruments in the most important countries of the continent. Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela are singled out for a deeper level of analysis. The countries of Bolivia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador,...
The Market for Library Preparation and Target Enrichment for Next-Generation Sequencing 2021
Published: July 28, 2021 | Price: $4,000.00 – $8,000.00
The Market for Library Preparation and Target Enrichment for Next-Generation Sequencing This report, Market for Library Preparation and Target Enrichment for Next-Generation Sequencing (NGS) examines the current market, providing a comprehensive market summary, including NGS sample preparation revenues and growth rates for 2021-2026 and NGS sample preparation revenues by geographic region for 2020 (North America, Europe, Asia-Pacific, rest-of-world). The introduction of smaller, cheaper benchtop NGS systems has expanded the market into smaller labs that could never afford prices for earlier...
In Vitro Diagnostics (IVD) Market in China, 2021
Published: September 29, 2021 | Price: $4,000.00 – $8,000.00
As an in vitro diagnostics (IVD) market, China trails only the populous, developed economy markets of the United States, western European countries, and Japan. The country and its healthcare system are confronted by challenges shared by less developed countries, but also burdens common among developed middle-income and affluent countries such as diabetes, cardiovascular disease, and diseases of aging. China as an IVD market opportunity is defined by its standing next to other populous countries with demonstrated economic promise for over...
Prescription Dermatological Drugs: Worldwide Market, 6th Edition
Published: January 1, 2008 | Price: $4,200.00 – $7,800.00
One of Kalorama's best-selling market research reports, this report provides the reader with a complete analysis of the domestic and international markets for pharmaceuticals to treat skin diseases and disorders. This edition of Worldwide Market for Prescription Dermatological Drugs is the sixth time Kalorama Information has comprehensively studied the dermatology markets. Kalorama has completely re-evaluated the market from the ground up, and in addition to the usual primary research (interviews) of industry participants, clinicians, and regulators, we also conducted scores...
The Worldwide Market for Cancer Diagnostics, 4th Edition
Published: April 1, 2010 | Price: $4,200.00 – $8,400.00
Since Kalorama Information last updated our comprehensive market report on cancer testing, changes in the industry abound. Developments that were novel two years ago such as the commercialization of service products , PGx testing and tissue microarrays are showing an increased presence. Some companies who promised much in the past have not produced results. And new entrants have entered the field. These changes and more are addressed in Kalorama Information's Worldwide Market for Cancer Diagnostics, 4th. Edition. This report authored...
Lateral Flow Technology And The Future Of Point Of Care Diagnostics, 2nd Edition
Published: August 1, 2013 | Price: $4,200.00 – $8,400.00
Lateral flow tests, also known as immunochromatographic strip (ICS) tests, are point of care tests that reduce the time spent waiting for test results from hours to minutes, require less training for operators, and reduce the cost of both device development and care. This report, Lateral Flow Technology and the Future of Point of Care Testing, 2nd Edition, takes an in depth look at the market, technologies, and trends in lateral flow point-of-care testing, looking at both self-testing by patients...
Proteomics Markets for Clinical IVD Applications and Research Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies)
Published: September 4, 2014 | Price: $4,200.00 – $8,400.00
Proteomics Markets for Clinical IVD Applications and Research Applications Kalorama Information report Proteomics Markets for Research and IVD Applications contains market estimates, forecasts and competitive analysis of this important area. Proteomics is the science of proteins, including the study of the function and form proteins. This includes the study of how and why proteins are expressed and how they interact with each other. Proteomics is a large field that has focused on research markets but has applications in therapeutics and...
Proteomics Research Markets: Instruments & Consumables (Mass Spectrometry, Liquid Chromatography, Electrophoresis), Disease Areas (Oncology, Cardio/Blood, Neurology, Other), Market Share and Trends
Published: May 13, 2015 | Price: $4,200.00 – $8,400.00
Proteomics research is increasingly involved in the development of modern clinical medicine from the identification of drug targets, the validation of biomarkers, and optimization of resulting drug leads and assays. Pharmaceutical and diagnostic companies spend tens of billions of dollars on translational research, which has increased the focus on instruments capable of powerfully assaying and identifying proteins implicated in disease pathways. This report defines the proteomics research market for major technologies. Report analyst Emil Salazar examines proteomics research processes...
The Market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Published: June 19, 2015 | Price: $4,200.00 – $8,400.00
The Market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Circulating tumor cells (CTCs) have tremendous utility in cancer research, aiding researchers in deciphering the complex processes leading to cancer metastasis and in developing more effective cancer therapeutics. Besides the research applications, the detection and analysis of CTCs has enormous potential in the diagnosis and management of cancer, as current tools, such as tumor tissue biopsy or imaging technologies, have numerous limitations. Although their biology and characteristics are...
The Market for Direct-to-Consumer Genetic Health Testing
Published: January 10, 2018 | Price: $4,200.00 – $7,990.00
The Market for Direct-to-Consumer Genetic Health Testing The Market for Direct-to-Consumer Genetic Health Testing provides an overview of the laboratory testing industry for advanced genetic tests. Market trends covered include world DTC genetic testing revenues, 2017-2022; revenues and growth for the U.S. European, Asia Pacific, and rest of world DTC genetic testing market, 2017-2022; genetic testing market drivers and barriers; and global DTC genetic testing market analysis featuring genetic testing volume distribution for genetic testing services by order origination source...
Clinical Diagnostics in India – Market Sector Analyses and Participant Directory
Published: December 1, 2006 | Price: $4,500.00 – $9,990.00
The current population of India is 1.065 billion, and with a growth rate of 1.7%, India will surpass China to become the world’s largest country around 2030. For diagnostic manufacturers, this enormous market is just now being recognized as a high-growth area as the pace of economic growth in India accelerates and modern laboratory practices become established. This comprehensive report on the market for clinical in vitro diagnostic (IVD) tests in India covers both reagent and instrumentation markets for the...
World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas)
Published: January 9, 2013 | Price: $4,500.00 – $9,000.00
Molecular diagnostics is becoming a dominant platform in clinical medicine and represents one of the fastest growing segments of the IVD market. As analyst Shara Rosen, R.T., MBA. details, in recent years years the number of assays introduced has been growing at a remarkable clip. This report, The World Market for Molecular Diagnostics (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas) represents the fifth time that Kalorama has conducted a complete study into the market for molecular diagnostics. Comprehensive Coverage...